Increasing Healthcare Expenditure Is Majorly Driving The Global Clinical Chemistry Markets

According to a recently published report, the global Clinical Chemistry Market is expected to grow at the 5.93%CAGR during the forecast period 2016-2022. The global clinical chemistry market is segmented on the basis of product, test end user and geography. The report on global clinical chemistrymarket forecast 2016-2022 (by product, test, end userandgeographically) provides detailed overview and predictive analysis of the market.

Full report available global clinical chemistrymarket forecast 2016-2022 (byproduct, test, end userand geographically)report at http://www.briskinsights.com/report/clinical-chemistry-market

In the clinical laboratories clinical chemistry analyzers are the most widely equipment.Medical biochemistry, clinical biochemistry or clinical pathology are also known as the clinical chemistry. Clinical chemistry term is basically used to find out the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecules which is easily-collected in the bodily fluids such as blood, serum, plasma or urine.

Clinical chemistry market is majorly driven by factors such as increasing health care expenditure globally. The awareness for better healthcare among the growing population of the emerging countries is continuously increasing.North America is dominating the clinical chemistry market due to increasing healthcare expenditure in which the U.S. is majorly contributing for its dominance. According to CMS in 2015 the healthcare expenditure in the U.S. is $3.207 trillion as compared to 2014 which was $3trillions. In Asia Pacific China is likely to be the major contributor to grow the market globally due to the high healthcare expenditure. The expenditure of China is continuously increasing in healthcare. In 2015 the annual expenditure by China for health care is about 11.8% in a year and during the forecast period it is predicted to reach approx. $900 billion. Clinical chemistry market has been segmented into the four parts such as- by product, test, end user and geographically. Product segment is dominating by reagents; test segment is dominating by the basic metabolic panel tests, end user segment is dominating by the diagnostic laboratory tests and geographically basis North America is dominating the global clinical chemistry market. Some of the key market drivers are elder population, reagent rental agreements, laboratory automation and more.

Scope of the report

1. GLOBAL CLINICAL CHEMISTRY MARKET BY PRODUCT 2012-2022 ($ MILLION)
1.1. Analyzers
1.2. Reagents
1.3. Other Products

2. GLOBAL CLINICAL CHEMISTRY MARKET BY TEST 2012-2022 ($ MILLION)
2.1. Basic Metabolic Panels
2.2. Electrolyte Panels
2.3. Liver Panels
2.4. Lipid Profiles
2.5. Renal Profiles
2.6. Thyroid Function Panels
2.7. Specialty Chemical Tests

3. GLOBAL CLINICAL CHEMISTRY MARKET BY END USER 2012-2022 ($ MILLION)
3.1. Academic Research Centers
3.2. Diagnostic Laboratories
3.3. Hospitals
3.4. Other End Users

4. GLOBAL RENEWABLE CHEMICAL MANUFACTURING MARKET REGIONAL OUTLOOK 2012-2022($ MILLION)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Latin America

5. COMPANY PROFILES
5.1. Abbott Laboratories
5.2. Beckman Coulter, Inc.
5.3. Danaher Corporation
5.4. Elitech Group
5.5. F. Hoffmann-La Roche Ltd.
5.6. Hitachi Ltd.
5.7. Horiba, Ltd.
5.8. Johnson & Johnson
5.9. Mindray Medical International Limited
5.10. Nova Biomedical Corporation
5.11. Ortho-Clinical Diagnostics, Inc.
5.12. Randox Laboratories Ltd.
5.13. Roche
5.14. Siemens AG
5.15. Thermo Fisher Scientific Inc.